JADENU

Identification of Jadenu

No description

Google image searchProduct monograph

Active ingredient

deferasirox, 180 MG

DIN: 02452227

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 24-MAR-2016

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AC — Iron chelating agents (ATC, ATC/DDD)
• V03AC03 — DEFERASIROX (ATC/DDD)

Reference brand drug: Exjade

External Links for Jadenu

Search on Google

• Jadenu side effects
• Jadenu dosage
• deferasirox side effects
• deferasirox dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find jadenu photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.